These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30788715)

  • 41. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
    Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
    Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
    Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.
    Cao H; Ooi M; Yu Z; Wang Q; Li Z; Lu Q; Wu Y
    J Gastrointest Surg; 2019 Feb; 23(2):256-263. PubMed ID: 30334176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study.
    Fujitani K; Miyashiro I; Mikata S; Tamura S; Imamura H; Hara J; Kurokawa Y; Fujita J; Nishikawa K; Kimura Y; Takiguchi S; Mori M; Doki Y
    Gastric Cancer; 2013 Jul; 16(3):301-8. PubMed ID: 22895616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of the number of metastatic lymph nodes in early gastric cancer.
    Gunji Y; Suzuki T; Hori S; Hayashi H; Matsubara H; Shimada H; Ochiai T
    Dig Surg; 2003; 20(2):148-53. PubMed ID: 12686784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How Should We Measure the Quality of Lymphadenectomy for Gastric Cancer? Anatomical Versus Numerical Criterion.
    Rausei S; Galli F; Lianos G; Rosa F; Cossu A; Biondi A; Martignoni F; Cananzi FCM; Fumagalli U; Alfieri S; Persiani R; Quagliuolo V; D'Ugo D; Rosati R
    J Gastrointest Cancer; 2020 Sep; 51(3):887-892. PubMed ID: 31691087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy.
    Lee J; Kim YM; Woo Y; Obama K; Noh SH; Hyung WJ
    Surg Endosc; 2015 Nov; 29(11):3251-60. PubMed ID: 25631106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term Outcomes of Laparoscopy-assisted Gastrectomy for T4a Advanced Gastric Cancer: A Single-center Retrospective Study.
    Zhang L; Zang L; Sun J; Dong F; Feng B; Lu AG; Wang ML; Zheng MH; Ma JJ; Hu WG
    Surg Laparosc Endosc Percutan Tech; 2019 Dec; 29(6):476-482. PubMed ID: 31259865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimally invasive surgery for gastric cancer: the American experience.
    Greenleaf EK; Sun SX; Hollenbeak CS; Wong J
    Gastric Cancer; 2017 Mar; 20(2):368-378. PubMed ID: 26961133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?
    Biondi A; D'Ugo D; Cananzi FC; Papa V; Borasi A; Sicoli F; Degiuli M; Doglietto G; Persiani R
    Eur J Surg Oncol; 2015 Jun; 41(6):779-86. PubMed ID: 25899981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
    Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
    Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Skeletonizing en-bloc gastrectomy for adenocarcinoma in Caucasian patients.
    Collard JM; Malaise J; Mabrut JY; Kestens PJ
    Gastric Cancer; 2003; 6(4):210-6. PubMed ID: 14716514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma.
    Spolverato G; Ejaz A; Kim Y; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby DA; Worhunsky D; Saunders N; Cho CS; Levine EA; Maithel SK; Pawlik TM
    Ann Surg; 2015 Dec; 262(6):991-8. PubMed ID: 25563867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative.
    Gholami S; Janson L; Worhunsky DJ; Tran TB; Squires MH; Jin LX; Spolverato G; Votanopoulos KI; Schmidt C; Weber SM; Bloomston M; Cho CS; Levine EA; Fields RC; Pawlik TM; Maithel SK; Efron B; Norton JA; Poultsides GA
    J Am Coll Surg; 2015 Aug; 221(2):291-9. PubMed ID: 26206635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis?
    Zhang J; Zou S; Luo R; Zhu Z; Wang Z; Xu H; Huang B
    Clin Transl Oncol; 2019 Dec; 21(12):1699-1706. PubMed ID: 30977046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Routinely staging gastric cancer with
    Findlay JM; Antonowicz S; Segaran A; El Kafsi J; Zhang A; Bradley KM; Gillies RS; Maynard ND; Middleton MR
    Eur Radiol; 2019 May; 29(5):2490-2498. PubMed ID: 30643947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
    Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
    J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study.
    Roviello F; Marrelli D; Morgagni P; de Manzoni G; Di Leo A; Vindigni C; Saragoni L; Tomezzoli A; Kurihara H;
    Ann Surg Oncol; 2002 Nov; 9(9):894-900. PubMed ID: 12417512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The RML of lymph node metastasis was superior to the LODDS for evaluating the prognosis of gastric cancer.
    Liu H; Deng J; Zhang R; Hao X; Jiao X; Liang H
    Int J Surg; 2013; 11(5):419-24. PubMed ID: 23541652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.